About this product
Deadband 12 was crafted through the expert crossing of Guava Cream 5 with Deadband #7 crossed with Guava Cream 5 (male). This genetic fusion has resulted in a strain characterized by its dense, well-structured buds that promise both visual appeal and elevated potency. A standout feature of Deadband 12 is its aromatic profile, exuding a delightful blend of sweet, funky, and citrus notes that are sure to entice the senses. The flavor mirrors this aromatic allure, offering a harmonious taste that perfectly complements its promises. Ideal for those seeking a unique and powerful experience, Deadband 12 stands out in the market with its distinctive qualities and robust effects.
We couldn’t find this item at any stores nearby. Check back later or view similar products.
view similar productsAbout this product
Deadband 12 was crafted through the expert crossing of Guava Cream 5 with Deadband #7 crossed with Guava Cream 5 (male). This genetic fusion has resulted in a strain characterized by its dense, well-structured buds that promise both visual appeal and elevated potency. A standout feature of Deadband 12 is its aromatic profile, exuding a delightful blend of sweet, funky, and citrus notes that are sure to entice the senses. The flavor mirrors this aromatic allure, offering a harmonious taste that perfectly complements its promises. Ideal for those seeking a unique and powerful experience, Deadband 12 stands out in the market with its distinctive qualities and robust effects.
No product reviews
Have you tried this product? Be the first to leave a review!
About this brand
Evermore Cannabis Company
Evermore Cannabis Company is Maryland's trusted source for premium cannabis. Rooted in passion and crafted by local experts—scientists, cultivators, chefs, and artisans—we deliver exceptional products that set the standard for quality. From seed to creation, Evermore pioneers innovation in cannabis, offering top-tier flower, concentrates, edibles, and more. Experience the best of Maryland cannabis with Evermore.
Notice a problem?Report this item